A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help ...
The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...
Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...
The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...
The US Food and Drug Administration (FDA) has expanded the indication for Tandem Diabetes Care’s Control-IQ+ Technology to include people with type 2 diabetes (T2D). The next-generation Control-IQ+ ...
Diabetes is a common condition that affects about 38 million people in the United States, and nearly 95% of those diabetes cases are type 2 diabetes. Potential symptoms may include frequent peeing, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results